Navigation Links
New Survey Reveals that Communication Breakdown Between Physicians and Patients Hinders Weight Loss Efforts
Date:11/13/2013

WOODCLIFF LAKE, N.J., Nov. 13, 2013 /PRNewswire/ -- A new survey conducted by Eisai Inc., in partnership with the Obesity Action Coalition (OAC) and The Obesity Society (TOS), reveals a disconnect between patients and physicians when discussing weight loss. The survey found that only 56 percent of overweight or obese adults report ever having discussed weight with their doctor, yet all physicians surveyed say they counsel their overweight and obese patients about diet and exercise. Less than four in 10 of those adults said they have been told to lose weight.

The survey was conducted to better understand if the communication about weight loss between patients and physicians was taking place. The two-part study consisted of a consumer survey of 1,009 adults and a survey of 501 physicians.

Overview of Survey Findings:

  • Nearly all physicians (92 percent) say they discuss Body Mass Index (BMI) with their overweight/obese patients, yet two out of three adults (67 percent) who have discussed weight with their physician say BMI was rarely or never part of that discussion
  • Nearly all physicians say they offer weight loss tools, but many patients (37 percent) believe their physicians can't help them lose weight
  • Less than two in 10 Americans (17 percent) know their BMI, and a disconnect exists in understanding what BMI means. More people think they have a normal BMI than actually do (43 percent versus 36 percent), and while two-thirds have a high BMI, only half of them know it.
  • Although many patients feel hopeful (41 percent) and motivated (20 percent) following a weight loss discussion with their physician, some adults also reported feelings of guilt (20 percent) and embarrassment (18 percent).
  • "With obesity rates continuing to escalate across the nation, improving the patient/physician relationship is critically important in the evaluation and treatment of patients who are affecte
    '/>"/>

    SOURCE Eisai Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Surveyed EU5 Oncologists Plan Increased Uptake of Perjeta for HER2-Positive Breast Cancer, But Expect Reimbursement Hurdles for Perjeta Plus Kadcycla
    2. Surveyed Physicians Report that Invokana Captures a Small Percentage of Patient Share in the Type 2 Diabetes Drug Market, With Significant Increases Expected Six Months from Now
    3. Surveyed U.S. Rheumatologists are Moderately Satisfied with Biologic Agents and Xeljanz to Treat Rheumatoid Arthritis
    4. More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely Candidates for FG-4592/ASP1517, According to Surveyed EU5 Nephrologists
    5. At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist
    6. Should Mircera Reach the U.S. Market, Surveyed Nephrologists State that at Least 40 Percent of CKD-ND and Dialysis Patients are Likely Candidates
    7. Half of all Pregnant Women Getting Flu Shots; Vaccination Rates Increase for Health Care Personnel, Surveys Find
    8. New Survey Reveals U.S. Men with Advanced Prostate Cancer Worry More about Burdening Family and Friends Than Dying
    9. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
    10. Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other Oral Multiple Sclerosis Therapies
    11. At One Month Post-Launch, Nearly One-Quarter of Surveyed U.S. Medical Oncologists Have Prescribed Xofigo to Their Prostate Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2014)... Aug. 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... of pharmaceutical development, clinical trial manufacturing, and advanced analytical ... that it will participate at the upcoming Rodman & ... be held in New York . ... on September 9, 2014 at the New York Palace ...
    (Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
    (Date:8/27/2014)... Aug. 27, 2014 /CNW/ - Covalon Technologies Ltd. (the "Company" ... the following financial results for its third quarter of fiscal ... 2014: , Revenue of $1,291,378, a 13% decrease ... Net loss for the quarter of $240,156 compared to net ... year For the nine months ended June ...
    Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
    ... from Biodel Inc. (Nasdaq: BIOD ) reported ... basal insulin and stabilized glucagon development programs in poster ... Technology Meeting in Bethesda, MD.   Dr. ... double-blind, randomized crossover trial in 13 subjects with type ...
    ... (NYSE Amex: NBS ) ("NeoStem" or the ... revenues, global research and development capabilities and operations in ... adult stem cells, and China pharmaceuticals, is today providing ... Third Quarter Results Revenues for the nine ...
    Cached Medicine Technology:Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 2Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 3Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 4Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 5NeoStem Provides Third Quarter Update 2NeoStem Provides Third Quarter Update 3
    (Date:8/27/2014)... The genome we inherited from our parents shapes many ... genome we have an epigenome that is set during ... and environmental exposuresand perhaps by those of our parents ... on our DNA and supporting proteins that determine whether ... are deeply responsible for our own health, but also ...
    (Date:8/27/2014)... growth in health care spending for commercially insured individuals ... services, rather than increased use, according to a new ... Health Policy & Clinical Practice, published in the August ... . , There is increasing concern that consolidation in ... faced by payers and, ultimately, consumers," said Carrie Colla, ...
    (Date:8/27/2014)... NJ (PRWEB) August 27, 2014 ... leading pediatric practice, Hoboken Pediatrics has joined our ... Dr. Andrzej Klos, Dr. Piotr Oko, Dr. Yanina ... Hundreds of highly skilled and experienced physicians comprise ... top doctors and practices in Hudson County, representing ...
    (Date:8/27/2014)... Scientists at The Scripps Research Institute (TSRI) have ... can be associated with alcohol dependence. , This ... type 1 (Nf1), which TSRI scientists found is linked ... Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter that lowers ... novel and seminal study provides insights into the cellular ...
    (Date:8/27/2014)... Silver Spring and Germantown, Md., and Denver (PRWEB) August ... healthcare real estate developer , has broken ground ... on the new Holy Cross Health hospital campus in ... of Bethesda, Md. Germantown is the third most populous ... medical office building on the Holy Cross Germantown Hospital ...
    Breaking Medicine News(10 mins):Health News:Scientists map the 'editing marks' on fly, worm, human genomes 2Health News:Scientists map the 'editing marks' on fly, worm, human genomes 3Health News:Scientists map the 'editing marks' on fly, worm, human genomes 4Health News:Tracking spending among the commercially insured 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 2Health News:Hoboken Pediatrics Joins CarePoint Health Medical Group 3Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4
    ... Since mephedrone was made illegal in the UK in 2010, the ... degraded, which in turn may have reduced use of the drug. ... continued to use mephedrone after it became illegal would switch to ... by their friends or on the Internet. They would be ...
    ... health records (EHRs) are rapidly becoming part of the ... of care. In the first large study of its ... Nursing determined that nurses working with EHRs consistently reported ... for patients than nurses working in hospitals without this ...
    ... , TUESDAY, Jan. 17 (HealthDay News) -- With the Alzheimer,s ... ages, a panel of experts is meeting for two days ... fast emerging as one of the nation,s biggest -- and ... is to improve diagnosis, buttress support and training programs for ...
    ... drug called regorafenib slowed the progression of tumors and lengthened ... an international phase III clinical trial found. The findings were ... American Society of Clinical Oncology in San Francisco by ... principal investigator of the trial in the United States. ...
    ... are performed on all newborns born in the U.S. ... are not apparent at birth. These newborn screening programs ... early and improve outcomes in potentially devastating conditions. ... the data collection linked to newborn screening results, aiming ...
    ... Jan. 16, 2012 Listen up, pedestrians wearing headphones. ... Many probably can,t, especially young adult males. Serious ... in six years, according to new research from the University ... Medical Center in Baltimore. In many cases, the cars ...
    Cached Medicine News:Health News:Despite the risks, mephedrone users in the UK are ready to try the next legal high 2Health News:Better together - The RN and the EHR 2Health News:U.S. Wants to Buttress Alzheimer's Arsenal by 2025 2Health News:U.S. Wants to Buttress Alzheimer's Arsenal by 2025 3Health News:Drug improves survival of colorectal cancer patients, trial results show 2Health News:Newborn screening program aims to help transform treatments for genetic diseases detected at birth 2Health News:Newborn screening program aims to help transform treatments for genetic diseases detected at birth 3Health News:University of Maryland study: Headphone-distracted pedestrians face death, serious injury 2Health News:University of Maryland study: Headphone-distracted pedestrians face death, serious injury 3
    Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
    A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
    1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
    ... Cable System, designed for ... sublaminar interspinous fixation, non-displaced ... sternotomy closure. Consists of ... complete set of instruments ...
    Medicine Products: